|
|
Volumn 6, Issue 5, 2002, Pages 565-566
|
|
Success and setback: Another adverse event
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COMPLEMENTARY DNA;
GENE PRODUCT;
INTERLEUKIN 2 RECEPTOR;
RETROVIRUS VECTOR;
T LYMPHOCYTE RECEPTOR DELTA CHAIN;
T LYMPHOCYTE RECEPTOR GAMMA CHAIN;
VIRUS VECTOR;
ANGIOGENESIS;
BONE MARROW CELL;
BONE MARROW TRANSPLANTATION;
CANCER CELL;
CANCER RISK;
CLINICAL FEATURE;
COMBINED IMMUNODEFICIENCY;
DISEASE ASSOCIATION;
EDITORIAL;
FRANCE;
GENE ACTIVATION;
GENE EXPRESSION;
GENE INACTIVATION;
GENE INSERTION;
GENE MUTATION;
GENE THERAPY;
GENETIC TRANSDUCTION;
HUMAN;
INFANT;
LYMPHOCYTE COUNT;
LYMPHOCYTE PROLIFERATION;
MEDICAL DECISION MAKING;
MEDICAL LITERATURE;
MOLONEY LEUKEMIA ONCOVIRUS;
MUTAGENESIS;
NEWBORN DEATH;
RISK BENEFIT ANALYSIS;
T CELL LEUKEMIA;
T LYMPHOCYTE;
TREATMENT OUTCOME;
UNITED STATES;
VIRUS REPLICATION;
MALE;
METHODOLOGY;
VIRUS DNA CELL DNA INTERACTION;
INSERTION SEQUENCES;
MOLONEY MURINE LEUKEMIA VIRUS;
ONCOVIRINAE;
UNIDENTIFIED RETROVIRUS;
GENE THERAPY;
HUMANS;
INFANT;
LEUKEMIA, T-CELL;
MALE;
SEVERE COMBINED IMMUNODEFICIENCY;
VIRUS INTEGRATION;
|
|
EID: 0036852183
PISSN: 15250016
EISSN: None
Source Type: Journal
DOI: 10.1016/S1525-0016(02)90709-4 Document Type: Editorial |
|
Times cited : (8)
|
|
References (0)
|